Accès ouvert déclaré
2024
article
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study
Leonardo Santos Hoff, Parikshit Sen, Jessica Day, Mrudula Joshi, Arvind Nune, Elena Nikiphorou, Sreoshy Saha, Ai Lyn Tan, Samuel Katsuyuki Shinjo, Nelly Ziadé, Tsvetelina Velikova, Marcin Milchert, Kshitij Jagtap, Ioannis Parodis, Abraham Edgar Gracia‐Ramos, Lorenzo Cavagna, Masataka Kuwana, Johannes Knitza, Yi‐Ming Chen, Ashima Makol, Vishwesh Agarwal, Aarat Patel, John D Pauling, Chris Wincup, Bhupen Barman, Erick Adrian Zamora Tehozol, Jorge Rojas‐Serrano, Ignacio García‐De La Torre, I. J. Colunga-Pedraza, Javier Merayo‐Chalico, Okwara Celestine Chibuzo, Wanruchada Katchamart, Phonpen Akarawatcharangura Goo, Russka Shumnalieva, Lina El Kibbi, Hussein Halabi, Binit Vaidya, Syahrul Sazliyana Shaharir, A T M Tanveer Hasan, Dzifa Dey, Carlos Enrique Toro Gutiérrez, Carlo V. Caballero‐Uribe, James B Lilleker, Babur Salim, Tamer A. Gheita, Tulika Chatterjee, Oliver Distler, Miguel Ángel Saavedra, Hector Chinoy, Rohit Aggarwal, Latika Gupta, Yogesh Preet Singh, Rajiv Ranjan, Avinash Jain, Sapan C Pandya, Rakesh Kumar Pilania, Aman Sharma, Manesh Manoj M, Vikas Gupta, Chengappa Kavadichanda, Pradeepta Sekhar Patro, Sajal Ajmani, Sanat Phatak, Rudra Prosad Goswami, Abhra Chandra Chowdhury, Ashish Jacob Mathew, Padnamabha Shenoy, Ajay Asranna, Keerthi Talari Bommakanti, Anuj Shukla, Arun K. Pande, Prithvi Sanjeevkumar Gaur, Mahabaleshwar Mamadapur, Akanksha Ghodke, Kunal Chandwar, Esha Kadam, Zoha Zahid Fazal, Sinan Kardeş, Döndü Üsküdar Cansu, Reşit Yıldırım, Armen Yuri Gasparyan, Margherita Giannini, F. Maurier, Julien Campagne, Alain Meyer, Nicoletta Del Papa, Gianluca Sambataro, Fabiola Atzeni, Marcello Govoni, Simone Parisi, Gian Domenico Sebastiani, Enrico Fusaro, Marco Sebastiani, Luca Quartuccio, Franco Franceschini, Pier Paolo Sainaghi, Giovanni Orsolini, Rossella De Angelis, Maria Giovanna Danielli, Vincenzo Venerito, Silvia Grignaschi, Laura Andréoli, Daniele Lini, Alessia Alluno, Florenzo Iannone, Marco Fornaro, Lisa S Traboco, Suryo Anggoro Kusumo Wibowo, Jesus Loarce‐Martos, Sergio Prieto‐González, Raquel Aránega, Akira Yoshida, Ran Nakashima, Shinji Sato, N. Kimura, Yuko Kaneko, Takahisa Gono, Stylianos Tomaras, Fabian Proft, Marie‐Therese Holzer, Margarita Aleksandrovna Gromova, Mr Or Aharonov, Melinda Nagy‐Vincze, Zoltán Griger, Karen Schrieber, Ihsane Hmamouchi, Pr Imane El bouchti, Zineb Baba, Uyi Ima-Edomwonyi, Ibukunoluwa Dedeke, Airenakho Emorinken, Nwankwo Henry Madu, Abubakar Yerima, Hakeem Olaosebikan, A Becky, Ouma Devi Koussougbo, Elisa Palalane, Daman Langguth, Vidya Limaye, Merrilee Needham, Nilesh Srivastav, Marie Hudson, Océane Landon‐Cardinal, Wilmer Gerardo Rojas Zuleta, Álvaro Arbeláez-Cortés, Javier Cajas, José António Pereira Silva, João Eurico Fonseca, Olena Zimba, Bohdana Doskaliuk, Ho So, Manuel F. Ugarte‐Gil, Lyn Chinchay, José Proaño Bernaola, Victorio Pimentel, Hanan M. Fathi, Reem Hamdy A Mohammed, Ghita Harifi, Yurilís Fuentes-Silva, Karoll Cabriza, Jonathan Losanto, Nelly Colaman, Antonio Cachafeiro-Vilar, Generoso Guerra Bautista, Enrique Julio Giraldo Ho, Raúl González, Lilith Stange Nunez, M Cristian Vergara, Jossiell Then Báez, Hugo Alonzo, Carlos Benito Santiago Pastelin, Rodrigo García Salinas, Alejandro Quiñónez Obiols, Nilmo Chávez, Andrea Bran Ordóñez, Sandra Argueta, Daniel Quijivix, Gil Alberto Reyes Llerena, Radames Sierra-Zorita, Dina Arrieta, Eduardo Romero Hidalgo, Ricardo Saénz, Roberto Morales Idania Escalante M, Wendy Calapaqui, Ivonne Quezada, Gabriela Arredondo
1Citations signalées, ce qui n’est pas une note de qualité
79Institutions déclarées
25Pays d’affiliation déclarés
Rattachement africain : br, in, au, gb, bd, lb, fr, bg, pl, se, mx, it, jp, de, tw, us, Nigéria, th, sa, my, Ghana, co, pk, Égypte, ch.
Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
OBJECTIVES: The objective of this study was to explore the prevalence, characteristics and risk factors of COVID-19 breakthrough infections (BIs) in idiopathic inflammatory myopathies (IIMs) using data from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study. METHODS: A validated patient self-reporting e-survey was circulated by the COVAD study group to collect data on COVID-19 infection and vaccination in 2022. BIs were defined as COVID-19 occurring ≥14 days after two vaccine doses. We compared BI characteristics and severity among patients with IIMs, patients with other autoimmune rheumatic and non-rheumatic diseases (AIRD, nrAID), and healthy controls (HCs). Multivariable Cox regression models were used to assess the risk factors for BI, severe BI ,and hospitalizations among patients with IIMs. RESULTS: Among the 9449 included responses, BIs occurred in 1447 respondents (15.3%). The median age was 44 years [interquartile range (IQR) 21], 77.4% were female, and 182 BIs (12.9%) occurred among the 1406 patients with IIMs. Multivariable Cox regression among the data for patients with IIMs showed increasing age to be a protective factor for BIs [hazard ratio (HR) = 0.98, 95% CI = 0.97-0.99], and HCQ and SSZ use were risk factors (HR = 1.81, 95% CI = 1.24-2.64, and HR = 3.79, 95% CI = 1.69-8.42, respectively). Glucocorticoid use was a risk factor for a severe BI (HR = 3.61, 95% CI = 1.09-11.8). Non-white ethnicity (HR = 2.61, 95% CI = 1.03-6.59) was a risk factor for hospitalization. Compared with other groups, patients with IIMs required more supplemental oxygen therapy (IIMs = 6.0% vs AIRDs = 1.8%, nrAIDs = 2.2% and HCs = 0.9%), intensive care unit admission (IIMs = 2.2% vs AIRDs = 0.6%, nrAIDs and HCs = 0%), advanced treatment with antiviral or monoclonal antibodies (IIMs = 34.1% vs AIRDs = 25.8%, nrAIDs = 14.6% and HCs = 12.8%) and had more hospitalization (IIMs = 7.7% vs AIRDs = 4.6%, nrAIDs = 1.1% and HCs = 1.5%). CONCLUSION: Patients with IIMs are susceptible to severe COVID-19 BIs. Age and immunosuppressive treatments were related to the risk of BIs.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study
- Date Crossref
- 02/03/2024
- Éditeur
- Oxford University Press (OUP)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.
Les sujets associés
Inflammatory Myopathies and DermatomyositisSARS-CoV-2 and COVID-19 ResearchRheumatoid Arthritis Research and Therapies